Rs10494366

From SNPedia
Jump to: navigation, search

Orientationplus
is asnp
is mentioned by
dbSNPrs10494366
PheGenIrs10494366
nextbiors10494366
hapmaprs10494366
1000 genomesrs10494366
hgdprs10494366
ensemblrs10494366
gopubmedrs10494366
geneviewrs10494366
scholarrs10494366
googlers10494366
pharmgkbrs10494366
gwascentralrs10494366
openSNPrs10494366
23andMers10494366
23andMe allrs10494366
SNP Nexus

SNPshotrs10494366
SNPdbers10494366
MSV3drs10494366
GeneNOS1AP
Chromosome1
Orientationplus
GMAF0.4761
Position162115895
ReferenceGRCh38 38.1/141
Max Magnitude2
Geno Mag Summary
(G;G) Long QT interval
(G;T) 0 average QT interval
(T;T) 2 Shorter QT interval
? (G;G) (G;T) (T;T) 28
rs10494366, a SNP in the NOS1AP gene encoding the nitric oxide synthase I adaptor protein, accounts for some of the variation seen in abnormal heart rhythms, in particular, the QT interval. Based on studies totaling ~4,000 individuals of Caucasian ancestry, homozygotes for one allele have shorter QT intervals, while homozygotes for the other allele have a longer QT interval. [PMID 16648850]

A follow-up study determined that one rs10494366(G) allele was associated with a 3.8-ms (CI: 3.0 - 4.6ms, p=7.8x10(-20)) increase in QT interval duration, and two (G) alleles had twice that increase. No increase in risk for sudden death due to a cardiac problem was associated with this SNP, though. [PMID 17576865]

[PMID 18235038] rs10494366 minor homozygotes had a 9.3 msec longer QT interval compared to major homozygotes (p=5.7x10(-5)); rs10918594 minor homozygotes had a 12.5 msec longer QT interval compared to major homozygotes (p=1.5x10(-6)). Restricting analyses to the diabetic EAs strengthened the effect despite the reduction in sample size (11.3 msec difference, p=5.1x10(-5); 13.9 msec difference, p=1.6x10(-6), respectively).

[PMID 18551039] Patients with rs10494366(G;T) or (G;G) genotypes have an increased mortality risk (hazard ratio 2.8) compared to (T;T) genotypes upon treatment with sulfonylurea antidiabetic drugs. Glibenclamide is less effective in reducing glucose levels and mortality rates were higher compared with glibenclamide users with the (T;T) genotype. However, in tolbutamide and glimepiride users, the (G;T) and (G;G) genotypes were associated with a reduced mortality rate.

[PMID 19204306OA-icon.png] rs10494366, rs4657139 and rs16847548 were significantly associated with adjusted QT interval in whites. relative hazard of SCD associated with each C allele at rs16847548 was 1.31. rs12567209 was also independently associated with SCD in whites (relative hazard 0.57, 95% confidence interval 0.39 to 0.83, P=0.003). No significant associations observed in blacks.

GWAS
SNP rs10494366
PubMedID [PMID 16648850]
Condition QT interval prolongation
Gene NOS1AP
Risk Allele
pValue 1.00E-010
OR 4.9
95% CI 7.90 (NR) msec difference between homozygote


[PMID 19247217] Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation

OMIM610141
DescQT INTERVAL, VARIATION IN
Variant
Relatedalso
[PMID 19943157OA-icon.png] NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study



[PMID 19289301] SNP association and sequence analysis of the NOS1AP gene in SIDS

GWAS snp
PMID [PMID 20062063]
Trait Electrocardiographic traits
Title Several common variants modulate heart rate, PR interval and QRS duration
Risk Allele G
P-val 5E-22
Odds Ratio 12.20 [9.72-14.68] % SD increase


[PMID 20215044OA-icon.png] Relationship of Common Candidate Gene Variants to Electrocardiographic T-Wave Peak to T-Wave End Interval and T-Wave Morphology Parameters


[PMID 20538168] Polymorphisms in the NOS1AP Gene Modulate QT Interval Duration and Risk of Arrhythmias in the Long QT Syndrome

[PMID 20722683OA-icon.png] A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes





[PMID 21663814] 5 HT(3)-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalities


[PMID 22133205] Allelic variant of NOS1AP effects on cardiac alternans of repolarization during exercise testing


[PMID 17903306OA-icon.png] Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study.


[PMID 18785031] Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.


[PMID 18852197OA-icon.png] Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants.


[PMID 19019189OA-icon.png] Common candidate gene variants are associated with QT interval duration in the general population.


[PMID 19076153OA-icon.png] A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.


[PMID 19180230OA-icon.png] Multiple independent genetic factors at NOS1AP modulate the QT interval in a multi-ethnic population.


[PMID 19305408OA-icon.png] Common variants at ten loci influence QT interval duration in the QTGEN Study.


[PMID 19389826OA-icon.png] Linkage disequilibrium mapping of the replicated type 2 diabetes linkage signal on chromosome 1q.


[PMID 19587794OA-icon.png] Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies.


[PMID 20031603OA-icon.png] A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project.


[PMID 20305679OA-icon.png] A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.


[PMID 22019493] Cardiac levels of NOS1AP RNA from right ventricular tissue recovered during lead extraction.


GET Evidence
rs10494366
aa_change
aa_change_short
impact pathogenic
qualified_impact Insufficiently evaluated pathogenic
overall_frequency 0.4375
summary